Trepanowski et al. reported that circulating fetuin-A levels were elevated in conditions like obesity, T2D, non-alcoholic fatty liver disease, and metabolic syndrome while the changes associated with impaired insulin sensitivity and glucose tolerance [19]. Here, AHSG is linked to metabolic dysfunction-associated steatotic liver disease.